eyeforpharma Archives -

Cost-concerns-with-the-new-NHS-pricing-scheme-2

At eyeforpharma Daiichi Sankyo’s Manuel Reiberg spoke about why the industry should look to make drugs more affordable

Current pharma model “not sustainable” during COVID-19, says Daiichi’s UK lead

https://pharmaphorum.com/news/current-pharma-model-not-sustainable-during-covid-19-says-daiichis-uk-lead/

Hands of robot and human touching on global virtual network connection future interface. Artificial intelligence technology concept.

Digital/ Views & Analysis/ Views and analysis

Why Norgine is embracing AI chatbots for medical information

George Underwood AI, chatbots, eyeforpharma, Norgine 0 Comment

When European pharma company Norgine saw an unmet need in how patients were seeking information on one of

Why Norgine is embracing AI chatbots for medical information

https://pharmaphorum.com/views-analysis-digital/norgine-embracing-ai-chatbot/

News/ News/ R&D

Equal coronavirus vaccine access a “real issue”

George Underwood coronavirus vaccine, COVID-19, eyeforpharma, vaccines 0 Comment

Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided

Equal coronavirus vaccine access a “real issue”

https://pharmaphorum.com/news/equal-coronavirus-vaccine-access-real-issue/

Digital/ News/ News

COVID-19 the time for digital health companies to “prove their worth”

George Underwood coronavirus, COVID-19, eyeforpharma 0 Comment

Digital startup guru Jessica Federer has called on pharma to see the COVID-19 crisis as an opportunity to

COVID-19 the time for digital health companies to “prove their worth”

https://pharmaphorum.com/news/covid-19-digital-health-companies-prove-their-worth/

Digital/ News/ News

COVID-19 could cause ‘digital reset’ for pharma

George Underwood coronavirus, COVID-19, eyeforpharma 0 Comment

The COVID-19 crisis will lead to a “digital reset” in pharma that will completely change how companies interact

COVID-19 could cause ‘digital reset’ for pharma

https://pharmaphorum.com/news/covid-19-digital-reset-for-pharma/

News/ News/ R&D

Pharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’

George Underwood coronavirus, COVID-19, eyeforpharma 0 Comment

Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they

Pharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’

https://pharmaphorum.com/news/pharma-companies-that-dont-change-during-covid-19-will-be-new-kodaks-of-this-world/

Patients/ Views & Analysis/ Views and analysis

The many faces of patient-pharma co-creation

George Underwood eyeforpharma, Merck KGaA, patient centricity, patient engagement 0 Comment

Ahead of her appearance at eyeforpharma Barcelona, Merck’s director of patient advocacy and strategic partnerships, Vanessa Pott, tells

The many faces of patient-pharma co-creation

https://pharmaphorum.com/views-analysis-patients/the-many-faces-of-patient-pharma-co-creation-merck-eyeforpharma/

Patients/ Views & Analysis/ Views and analysis

eyeforpharma Patient Summit Europe roundup

mike.hammerton@pharmaphorum.com eyeforpharma, Patient Summit 0 Comment

eyeforpharma’s Patient Summit Europe brought together leading patient innovators from industry and patient associations for two days of

eyeforpharma Patient Summit Europe roundup

https://pharmaphorum.com/views-analysis-patients/eyeforpharma-patient-summit-europe-roundup/

Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Real world evidence, digital partnerships and the future of pharma

George Underwood AstraZeneca, eyeforpharma, Real World Evidence, RWE 0 Comment

Ahead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy &

Real world evidence, digital partnerships and the future of pharma

https://pharmaphorum.com/views-analysis-digital/real-world-evidence-digital-partnerships-and-the-future-of-pharma/

Trending

eyeforpharma

Login